SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-161680
Filing Date
2024-06-14
Accepted
2024-06-14 16:37:01
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d650467d10ka.htm   iXBRL 10-K/A 275483
2 EX-31.3 d650467dex313.htm EX-31.3 3357
3 EX-31.4 d650467dex314.htm EX-31.4 3313
  Complete submission text file 0001193125-24-161680.txt   527942

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aura-20231231.xsd EX-101.SCH 4580
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aura-20231231_cal.xml EX-101.CAL 660
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aura-20231231_def.xml EX-101.DEF 17025
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aura-20231231_lab.xml EX-101.LAB 23081
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aura-20231231_pre.xml EX-101.PRE 18581
21 EXTRACTED XBRL INSTANCE DOCUMENT d650467d10ka_htm.xml XML 8272
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40971 | Film No.: 241045445
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)